BridgeBio Pharma, Inc. BBIO
Set alert
75.85 USD +0.90 +1.20%
As of Nov 2, 3:21 PM ET
74.20 Day range 76.70
60.22 52-week range 93.42
- YTD
- -0.84%
- 1 year
- +21.09%
- Open
- 75.01
- Prev close
- 74.95
- Mkt cap
- 14.77B
- Vol
- 1.88M
- Avg vol
- 2.57M
- EPS
- -3.03
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 74.20
- High
- 76.70
- Forward P/E
- -333.67
- Beta
- 0.97
- Short ratio
- 6.50
- Inst. own
- 99.55%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 23, 2027
- 50-d avg
- 70.43
- 200-d avg
- 72.76
- 1y target
- 107.81
6M chart
Events in this range
- May 7, 2026Earnings: -0.84; estimate -0.67877; surprise -23.75%
- Aug 10, 2026Earnings: -0.78; estimate -0.57558; surprise -35.52%
- Oct 7, 2026Rating: Barclays · Overweight → Overweight
- Oct 19, 2026Rating: Piper Sandler · Overweight → Overweight
- Oct 19, 2026Rating: Citigroup · Neutral → Neutral
- Oct 21, 2026Rating: Morgan Stanley · Overweight → Overweight
- Oct 29, 2026Earnings: -0.42; estimate -0.54225; surprise 22.54%
- Oct 30, 2026Rating: Morgan Stanley · Overweight → Overweight
- Oct 30, 2026Rating: TD Cowen · Buy → Buy
Signals (16)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 2026 | 3 days ago |
| RSI: Overbought | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| MACD: Buy Signal | Oct 1, 2026 | 1 month ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| RSI: Oversold | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 21, 2026 | 3 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
Ownership
Held by insiders 3.91%
Held by institutions 99.55%
Float held by institutions 103.60%
Institutions 655
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Jupiter Topco LLC | 7.22% | 14,110,278 | 1.06B | Jun 29, 2026 |
| Kohlberg Kravis Roberts & Co. L.P. | 6.78% | 13,260,971 | 993.91M | Jun 29, 2026 |
| Farallon Capital Management LLC | 5.50% | 10,743,063 | 805.19M | Jun 29, 2026 |
| Blackrock Inc. | 5.26% | 10,287,156 | 771.02M | Jun 29, 2026 |
| Viking Global Investors, L.P. | 5.09% | 9,949,219 | 745.69M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.04% | 7,898,973 | 592.03M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.86% | 5,600,403 | 419.75M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.07% | 4,039,952 | 302.79M | Jun 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.62% | 3,162,851 | 237.06M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.19% | 2,330,329 | 174.66M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.01% | 1,974,544 | 147.99M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 0.99% | 1,942,329 | 145.58M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| APULI MARICEL | Officer | Sale | Jul 29, 2026 | 127,401 |
| HOMCY CHARLES J | Director | Stock Award(Grant) | Jun 21, 2026 | 919,876 |
| KKR GENETIC DISORDER L.P. | Beneficial Owner of more than 10% of a Class of Security | Sale | May 11, 2025 | 0 |
| KUMAR NEIL | Chief Executive Officer | Sale | Sep 16, 2026 | 0 |
| MCCORMICK FRANK P. PH.D. | Director | Stock Award(Grant) | Jun 21, 2026 | 767,244 |
| MOMTAZEE JAMES C | Director | Stock Award(Grant) | Jun 21, 2026 | 99,070 |
Held by funds
169 US ETFs and mutual funds hold BBIO · largest positions